Author:
Maielli Alessandra,Mornata Federica,Persico Pasquale,Capucetti Arianna,Bonecchi Raffaella,Simonelli Matteo,Locati Massimo,Borroni Elena Monica,Savino Benedetta
Publisher
Springer International Publishing
Reference114 articles.
1. Alliot F, Godin I, Pessac B (1999) Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 117:145–152
2. Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J, Hockenbery D, Houghton AM, Holland EC (2017) Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev 31:774–786
3. Attia N, Mashal M, Pemminati S, Omole A, Edmondson C, Jones W, Priyadarshini P, Mughal T, Aziz P, Zenick B, Perez A, Lacken M (2021) Cell-based therapy for the treatment of glioblastoma: an update from preclinical to clinical studies. Cell 11:116
4. Badie B, Schartner JM (2000) Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46:957–961; discussion 961–952
5. Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O’Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O’Reilly S (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 114:149–154